Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Bussel

Showing results (11-20 of 262) with videos related to

Pageof 27
Sort By:
British Journal of Haematology|August 29, 2023
Intramuscular anti-D treatment for immune thrombocytopenia-ResponseJames B Bussel
The Journal of Supportive Oncology|June 7, 2007
Novel thrombopoietic agents: preliminary activity, potential benefitJames B Bussel
Seminars in Hematology|February 28, 2009
Therapeutic approaches to secondary immune thrombocytopenic purpuraJames B Bussel
British Journal of Haematology|October 24, 2018
AvatrombopagJames B Bussel
The Journal of Clinical Investigation|July 26, 2008
Fc receptors in immune thrombocytopenias: a target for immunomodulation?Bethan Psaila, James B Bussel
Oncology (Williston Park, N.Y.)|October 21, 2011
Consider thrombotic microangiopathy in pediatric and hematopoietic stem cell transplant patientsRina Meyer, James B Bussel
Clinical Advances in Hematology & Oncology : H&O|February 14, 2015
Review of fetal and neonatal immune cytopeniasSharon Lewin, James B Bussel
British Journal of Haematology|October 13, 2023
Treatment of immune thrombocytopenia during pregnancy with thrombopoietin receptor agonistsAmihai Rottenstreich, James B Bussel
British Journal of Haematology|October 17, 2024
What is the best second-line treatment for immune thrombocytopenia?Matthieu Mahévas, James B Bussel
Presse Medicale (Paris, France : 1983)|April 1, 2014
Thrombopoietic agents: there is still much to learnJames B Bussel, Madhavi Lakkaraja
Pageof 27

Showing results (11-20 of 262) with videos related to

Sort By:
Pageof 27
British Journal of Haematology|August 29, 2023
Intramuscular anti-D treatment for immune thrombocytopenia-ResponseJames B Bussel
The Journal of Supportive Oncology|June 7, 2007
Novel thrombopoietic agents: preliminary activity, potential benefitJames B Bussel
Seminars in Hematology|February 28, 2009
Therapeutic approaches to secondary immune thrombocytopenic purpuraJames B Bussel
British Journal of Haematology|October 24, 2018
AvatrombopagJames B Bussel
The Journal of Clinical Investigation|July 26, 2008
Fc receptors in immune thrombocytopenias: a target for immunomodulation?Bethan Psaila, James B Bussel
Oncology (Williston Park, N.Y.)|October 21, 2011
Consider thrombotic microangiopathy in pediatric and hematopoietic stem cell transplant patientsRina Meyer, James B Bussel
Clinical Advances in Hematology & Oncology : H&O|February 14, 2015
Review of fetal and neonatal immune cytopeniasSharon Lewin, James B Bussel
British Journal of Haematology|October 13, 2023
Treatment of immune thrombocytopenia during pregnancy with thrombopoietin receptor agonistsAmihai Rottenstreich, James B Bussel
British Journal of Haematology|October 17, 2024
What is the best second-line treatment for immune thrombocytopenia?Matthieu Mahévas, James B Bussel
Presse Medicale (Paris, France : 1983)|April 1, 2014
Thrombopoietic agents: there is still much to learnJames B Bussel, Madhavi Lakkaraja
Pageof 27